Literature DB >> 7010882

Bacterial flora in relation to cataract extraction. V. Effects of topical antibiotics on the preoperative conjunctival flora.

J A Fahmy.   

Abstract

In a randomized study comprising 60 patients, six different prophylactic regimens were evaluated for their effectiveness in eradicating bacteria on the conjunctivas before surgery. Gentamicin sulfate ophthalmic solution was the only antibiotic able to eliminate bacteria in almost all of the examined patients. The other drugs (chloramphenicol solution, oxytetracycline-polymyxin B ointment, sulphamethizole, bacitracin-neomycin and ristocetin-polymyxin B solutions) were not effective, although most of the isolated strains were sensitive to the respective antibiotics, probably because of the short treatment period (18 h). The problem of prophylactic therapy of ophthalmology is discussed, and some guide lines are given.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7010882     DOI: 10.1111/j.1755-3768.1980.tb08298.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  4 in total

1.  Effect of preoperative fusidic acid on the normal eyelid and conjunctival bacterial flora.

Authors:  P B Taylor; K F Tabbara; E M Burd
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

2.  [Lavasept as an alternative to PVP-iodine as a preoperative antiseptic in ophthalmic surgery. Randomized, controlled, prospective double-blind trial].

Authors:  F Hansmann; A Kramer; H Ohgke; H Strobel; M Müller; G Geerling
Journal:  Ophthalmologe       Date:  2005-11       Impact factor: 1.059

3.  [Polyhexamethylbiguanid (PHMB) as preoperative antiseptic for cataract surgery].

Authors:  F Hansmann; A Kramer; H Ohgke; H Strobel; M Müller; G Geerling
Journal:  Ophthalmologe       Date:  2004-04       Impact factor: 1.059

4.  Experimental evaluation of chlorhexidine gluconate for ocular antisepsis.

Authors:  M B Hamill; M S Osato; K R Wilhelmus
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.